Top VC Firms in Switzerland
The 25 highest-scoring venture funds headquartered in Switzerland, ranked from 97 eligible firms on a 110-point composite of portfolio outcomes, deal volume, risk adjustment and cheque-size fit.
Investments
6
Exit Rate
17%
Alive
4
Portfolio Outcomes
Score Breakdown
Investments
38
Exit Rate
5%
Alive
29
Portfolio Outcomes
Score Breakdown
Investments
35
Exit Rate
5%
Alive
29
Portfolio Outcomes
Score Breakdown
Swisscom Ventures invests primarily in Swiss and nearby European technology startups focusing on software, robotics, and AI across seed to later stages. They target B2B business models supporting digital transformation and innovation.
Investments
15
Exit Rate
7%
Alive
13
Portfolio Outcomes
Score Breakdown
Investments
130
Exit Rate
12%
Alive
81
Portfolio Outcomes
Score Breakdown
Helvetica Capital is an independent, entrepreneurial investor focusing on companies in Switzerland and neighboring regions. They provide capital and advise both entrepreneurs and investors on financing and succession solutions.
Investments
26
Exit Rate
8%
Alive
23
Portfolio Outcomes
Score Breakdown
BioMedPartners invests in innovative early-stage healthcare and life science companies. They focus on companies developing novel therapeutics and diagnostics.
Investments
19
Exit Rate
0%
Alive
15
Portfolio Outcomes
Score Breakdown
Investments
10
Exit Rate
0%
Alive
9
Portfolio Outcomes
Score Breakdown
Lightrock Climate Impact Fund invests in innovative companies that combat climate change and promote sustainability, focusing on scalable solutions in energy, agriculture, and resource efficiency.
Investments
43
Exit Rate
5%
Alive
48
Portfolio Outcomes
Score Breakdown
Focuses on Series C and later stage investments in Switzerland. Primarily invests in B2B companies within the Industry & Hardware sector.
Investments
5
Exit Rate
0%
Alive
5
Portfolio Outcomes
Score Breakdown
Investments
264
Exit Rate
5%
Alive
235
Portfolio Outcomes
Score Breakdown
Investments
11
Exit Rate
0%
Alive
11
Portfolio Outcomes
Score Breakdown
Focuses on investments in the healthcare and life sciences sector. Primarily invests in companies located in Switzerland.
Investments
10
Exit Rate
20%
Alive
7
Portfolio Outcomes
Score Breakdown
Focuses on early-stage companies in the healthcare and life sciences sector, primarily in Europe. They look for innovative solutions that improve patient outcomes and healthcare delivery.
Investments
14
Exit Rate
7%
Alive
8
Portfolio Outcomes
Score Breakdown
Vorwerk Ventures invests in early-stage consumer and lifestyle companies, primarily in Switzerland. They focus on innovative B2C business models with high growth potential.
Investments
25
Exit Rate
4%
Alive
15
Portfolio Outcomes
Score Breakdown
Focuses on Series C and later stage investments in Swiss Industry & Hardware companies.
Investments
20
Exit Rate
10%
Alive
16
Portfolio Outcomes
Score Breakdown
Investments
106
Exit Rate
—
Alive
—
Portfolio Outcomes
Not enough tracked outcomes yet
Score Breakdown
MTIP invests in innovative healthcare companies, primarily in the United States. They focus on later-stage companies with proven business models.
Investments
17
Exit Rate
0%
Alive
19
Portfolio Outcomes
Score Breakdown
Zintinus invests primarily in Series B startups based in Switzerland and Germany, focusing on scaling innovative ventures with significant growth potential.
Investments
10
Exit Rate
0%
Alive
12
Portfolio Outcomes
Score Breakdown
Versant Ventures invests primarily in early-stage biopharmaceutical and healthcare companies in North America and Europe, focusing on innovative therapeutics and medical technologies with transformative potential.
Investments
26
Exit Rate
4%
Alive
25
Portfolio Outcomes
Score Breakdown
Syngenta Ventures invests in innovative Agtech and sustainable agriculture startups globally, focusing on scalable solutions that enhance crop protection, digital farming, and biotechnology to improve food security and environmental impact.
Investments
25
Exit Rate
3%
Alive
21
Portfolio Outcomes
Score Breakdown
Novartis Venture Funds invests in innovative healthcare startups focusing on breakthrough therapies and technologies. They target scalable companies primarily in biotech and digital health sectors with the potential to transform patient care.
Investments
28
Exit Rate
0%
Alive
23
Portfolio Outcomes
Score Breakdown
Focuses on investments in the consumer, lifestyle, and services sectors. Primarily invests in companies located in the United States.
Investments
42
Exit Rate
0%
Alive
38
Portfolio Outcomes
Score Breakdown
Investments
20
Exit Rate
5%
Alive
18
Portfolio Outcomes
Score Breakdown
Investments
64
Exit Rate
4%
Alive
56
Portfolio Outcomes
Score Breakdown
Methodology
What the score measures, who is eligible, and what it deliberately excludes.
- How is the Brouky score for Switzerland calculated?
- Each firm is scored out of 110 points across four measured components: portfolio outcomes (40), deal volume (30), risk adjustment (25) and cheque-size fit (15). The score is computed from tracked investments and portfolio company status. It is not editorial and firms cannot influence it.
- Which firms are eligible for the Switzerland ranking?
- Venture and corporate venture funds headquartered in Switzerland with at least 5 tracked investments. 97 firms qualify; the top 25 are listed. Angel investors, family offices, banks, accelerators and government vehicles are excluded because they are scored on a different basis and are not comparable.
- How often is the ranking updated?
- Scores are recomputed as new investments and portfolio outcomes are recorded, and this page refreshes daily.
- My fund's data looks wrong. Can it be corrected?
- Yes. Claim the fund's profile on Brouky to review the underlying investments and portfolio records, and the score updates from the corrected data.